Patent
Treatment for Dupuytren's disease
- Documentation:
- Musculoskeletal fibroproliferative disorders, such as Dupuytren's disease may be treated by administering locally a TNF-alpha antagonist. TNF-alpha antagonists find particular utility in inhibiting the progression of early disease state Dupuytren's disease and other musculoskeletal fibroproliferative disorders and, in combination with extracellular matrix degradation agents (such ascollagenase or matrix metalloproteinase I), treating advanced disease state Dupuytren's disease and, in particular inhibiting recurrence.
- Publication status:
- Published
Actions
Access Document
- Files:
-
-
(Version of record, 5.7MB)
-
Authors
Funding
Bibliographic Details
- Publication date:
- 2013-10-31
- Event end date:
- 2031-10-31
- Territory:
- USA
- Patent number:
-
US20130287760A1
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1108394
- Local pid:
- pubs:1108394
- Deposit date:
- 2020-06-02
Terms of use
- Copyright holder:
- © Nanchahal and Midwood
- Copyright date:
- 2013
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record